Earlier this month C.R. Bard Inc., a New Jersey based corporation that develops, manufactures, and markets medical products, agreed to pay $48.26 million to resolve kickback allegations filed against the company relating to its sale of Brachytherapy seeds.
Brachytherapy seeds are a form of radiation therapy. According to the complaint filed in 2006, Bard allegedly paid illegal kickbacks in numerous forms to both physicians and other customers who used the seeds to perform treatment for prostate cancer. Specifically, Bard was accused of paying illegal kickbacks in the form of grants, guaranteed minimum rebates, conference fees, marketing assistance, and free medical equipment. According to the allegations, Bard caused false claims to be submitted to Medicare when hospitals ultimately submitted bills for treatments ordered as a result of a kickback scheme.
The whistleblower in this case, Julie Darity, was a former contracts administration officer for Bard’s Georgia office. Ms. Darity worked for Bard for 18 years and initially tried to report the kickbacks to her supervisors to no avail. She then decided to file her qui-tam lawsuit. Ms. Darity will receive $10,134,600 as her portion of the settlement.
If you have information about healthcare fraud, do not hesitate to act. For more information on how to find a qui tam law firm to represent you, please call (202) 973-0900 or fill out a Confidential Case Evaluation form.